AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
2
The man who helped build Palo Alto’s Cortex is leaving the company
3
Serbia opens Israeli drone factory as defense ties with Elbit deepen
4
“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B
5
Five months old, Noetive raises $41 million Seed to build AI for the physical economy
More news

Fosun Pharma

8 stories about Fosun Pharma
גיל נאור יזם מיטראסיסט

Israel's Mitrassist Medical raises $50 million for medical valve development

02.12.20|Meir Orbach
China's Fosun Pharma, insurance company Ping-An and four large Chinese funds all took part in the round
הזרקת חומר להמסת שומן בסנטר

Double-chin reducing Israeli startup closes $74 million China licensing deal

22.09.20|Meir Orbach
The agreement provides JuveStar with exclusive rights to develop and commercialize Raziel Therapeutics’ proprietary RZL-012 compound
מימין קאלואן פוסון ויליאם הו פוסום ליאור דיין מיסטר לואי

Fosun Whetted Our Appetite, Says Alma Lasers CEO

04.07.19|Golan Hazani
Fosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013
קיסריה קמפוס גרניט 2

Fosun Pharma Subsidiary Sisram Medical Leases 11,000-Square-Meter Building in Caesarea

10.12.18|Dotan Levy
The ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers
בורסת הונג קונג בורסה בורסות אסיה

Fosun Pharma Acquires Israeli Distributer Via Israeli Subsidiary Sisram

28.11.18|Golan Hazani
Sisram Medical, formerly Alma Lasers, is buying Nova Medical, one of the largest distributors of medical aesthetic devices in Israel
גואו גואנצ'אנג יו"ר קבוצת פוסון

Fosun Leads $30 Million Round for Heart Valve Company MitrAssist

08.11.17|Lilach Baumer
The Israel-based company develops a valve implant that can be installed through thigh catheterization instead of invasive heart surgery
בורסת הונג קונג בורסה בורסות אסיה

Sisram Stock Price Down on Market Debut

19.09.17|Amarelle Wenkert
The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
בורסת הונג קונג בורסה בורסות אסיה

Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO

10.09.17|Amarelle Wenkert
On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange